Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-02-25 @ 12:55 AM
Study NCT ID:
NCT04122820
Status:
UNKNOWN
Last Update Posted:
2019-10-18
First Post:
2019-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ambulatory Screening for Specific Learning Disabilities (SLD) and Developmental Coordination Disorder (DCD).
Sponsor:
CNGE IRMG Association
Organization:
Study Overview
Official Title:
Sensitivity of the Search for a Heterophory-Vertical-Labile (HV-Labile) for Ambulatory Screening for Specific Learning Disabilities (SLD) or Developmental Coordination Disorder (DCD).
Status:
UNKNOWN
Status Verified Date:
2019-10
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TDys
Brief Summary:
To evaluate, in primary care, the sensitivity of Heterophory-Vertical-Labile (HV-Labile) in ambulatory screening for Specific Learning Disabilities (SLD) and Developmental Coordination Disorder (DCD). in children aged 8 to 12 years.
Detailed Description:
General practitioners during a day of professional training on learning disabilities will be trained to perform the proprioceptive Maddox, to search for a HVLabile.
Each trained practitioner will then test at least six children aged 8 to 12 years old in his or her practice, seen at random
250 to 300 physicians will be trained as part of this research
EXPERIMENTAL DESIGN
* Cross-sectional study with prospective recruitment.
* Search for a Vertical Labile Heterophory (HV-Labile).
* Prescription of a standardized speech and language screening assessment for HV-Labile, and in the same number of children without HV-Labile by secondary coupling.
* Delivery of symptomatic questionnaire.
* In case of learning disabilities, the attending physician should look for a possible etiology.
* Adapted speech therapy care for more than six months.
* Speech and language therapy check-up at more than six months.
Each trained practitioner will then test at least six children aged 8 to 12 years old in his or her practice, seen at random
250 to 300 physicians will be trained as part of this research
EXPERIMENTAL DESIGN
* Cross-sectional study with prospective recruitment.
* Search for a Vertical Labile Heterophory (HV-Labile).
* Prescription of a standardized speech and language screening assessment for HV-Labile, and in the same number of children without HV-Labile by secondary coupling.
* Delivery of symptomatic questionnaire.
* In case of learning disabilities, the attending physician should look for a possible etiology.
* Adapted speech therapy care for more than six months.
* Speech and language therapy check-up at more than six months.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2019-A00416-51 | REGISTRY | ID-RCB | View |